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Aim. The aim of study was to compare the sensitivity of MRI and CTA for endoleak detection and classification after EVAR.
Patients & Methods. Twenty-eight patients, between 2 days and 65 months after EVAR, were evaluated with both CT
and MRI. Twenty-five patients had an Ancure graft and the other three had an Excluder. The MRI protocol for endoleak
evaluation included: a T1-weighted spin echo, a high-resolution 3D CE-MRA, and a post-contrast T1-weighted spin echo.
In total 40 ml Gadolinium was administered. The CT protocol consisted of a blank survey followed by a spiral CT angio-
graphy (CTA) using 140 ml of Ultravist. An experienced, blinded observer evaluated all CTs and MRIs.
Results. Using MRI and MRA techniques significantly more endoleaks (23/35) were detected than with CTA (11/35)
(p¼ 0.01, Chi-Square). CT could not determine the type of endoleak in 3 of the 11 endoleaks detected and was uncertain
in one. MRI was uncertain about the type in 14 of the 23 endoleaks detected. All endoleaks visible on CT were visible by
MRI as well.
Conclusions. MRI techniques are more sensitive for the detection of endoleak after endovascular AAA repair than CT.
Keywords: MRI; CTA; AAA; Endovascular; Endoleak; Imaging; Complications.Background
An important drawback of endovascular aneurysm
repair (EVAR) is the need for a post-operative surveil-
lance program. An intensive imaging schedule to
detect early or late complications, such as sac size in-
crease, endoleak or graft migration is required for the
rest of the patients life.1e4
Death from aneurysm rupture after EVAR is the ul-
timate proof of treatment failure. As the postoperative
rupture risk is extremely low, it will take many years
and large numbers of patients before the hard end-
point of rupture risk can be used as a representative
outcome measure.5e8 This long-term data is not yet
available. The evaluation of short term treatment suc-
cess has to rely on secondary and softer endpoints like
endoleak or aneurysm sac size change.
Endoleak is a frequent problem after EVAR. Com-
puted Tomography Angiography (CTA)-based studies
show that up to 20% of patients have an initial
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onstrated that all type I endoleaks create systemic
pressure inside the aneurysm sac.10e12 The risk of
rupture appears to be increased in these patients.7,11,13
Type II endoleaks can create high intra-sac pressures
too.10,11,14 Therefore some authors advise a more
aggressive approach towards type II endoleaks than
was previously thought necessary.7,11,13,15 Still, many
patients present with a shrinking aneurysm sac, de-
spite the presence of an endoleak. Whether these pa-
tients need to be treated remains controversial.7,15e17
However, in the presence of a new or a previously
undetected endoleak, some aneurysms can show
secondary growth after initial shrinkage.18 In our
opinion many cases of endotension, aneurysm sac
enlargement without a detectable endoleak, could be
attributed to a missed endoleak.19e21
Magnetic resonance imaging (MRI) techniques
have been shown to be very sensitive for depicting
small endoleaks.22e24 Because of the high sensitivity
to Gadolinium-based T1-shortening contrast agent,
the intrinsic three dimensionality and excellent soft
tissue contrast, MRI and magnetic resonance angiog-
raphy (MRA) techniques theoretically are well suited
for endoleak detection after EVAR.rved.
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CT scanning and abdominal x-ray. The CT data are
used for volume measurements, evaluation of endo-
leaks, graft patency and graft migration. The plain
abdominal radiograph is used for the evaluation of
stent-graft integrity. In the present study we focus
on the detection and classification of endoleaks.
The aim of this study was to compare the sensitiv-
ity of CT and MRI for the detection of endoleak. We
hypothesized that MRI is more sensitive for detection
of endoleaks than Computed Tomography (CT).
Patients & Methods
Patients
In the period between March 2001 and March 2003, 28
patients randomly selected from our EVAR follow-up
program were included in the study. This group con-
sisted of 26 males and 2 females with a mean age of
75 years (range 58e87 years). These patients were
scanned using CTA and with our MRI protocol. Three
patients had an Excluder endograft (Gore, Flagstaff,
AZ, USA) and 25 had an Ancure endograft (EVT,
Menlo Park CA, USA). There were 5 patients who
were evaluated twice with a 6 month or 1 year inter-
val and 1 patient was scanned three times with 6
months intervals in between. This resulted in 35 MRI
data sets and 35 CTA data sets. Institutional review
board approval was obtained and all included pa-
tients signed an informed consent form. Patients were
between 2 days and 65 month (mean 30 months) after
EVAR at the time of imaging.
Design
Patients underwent MRI as well as CT evaluation. The
MRI was added to our standard CT surveillance pro-
tocol. For practical reasons the 2 examinations could
not take place on the same day. The time between
the CT and the MRI exam was minimized and was
not allowed to exceed one month.
Scans from both imaging modalities were
evaluated for the presence of endoleaks and for the
determination of the type of endoleak. Endoleak was
scored as present, not present, or uncertain. Classifica-
tion of the endoleaks was performed as proposed by
White et al., type I, II, III, IV or unknown (meaning
the exact site of inflow could not be identified).25,26
The MRI images were evaluated by an experienced
observer blinded to the results of the CT.
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Computed tomography angiography: CT scans were
performed on a spiral CT scanner (AV-EP, Philips
Medical Systems, Best, The Netherlands). The table
speed used was 5 mm/sec with a reconstruction in-
dex of 2 mm. One non-contrast-enhanced scan and
one with an intravenous infusion of 140 ml Ultravist
(Berlex, Montville, NJ, USA) at 3 ml/sec with a 30 sec-
ond delay between the start of the injection and the
start of the scan were acquired at 120 kV and 250
mA with a matrix size of 250. In our standard CT pro-
tocol, delayed series (2 scans with a 2 minute and
a 4 minute interval after the CTA) were performed
if an endoleak was suspected, i.e. in case of a growing
or stable nonluminal volume of the aneurysm sac
based upon previous assessments.27
Magnetic resonance imaging and angiography:
MRI scans were performed on a clinical 1.5-T scanner
(Gyroscan Intera NT, Philips Medical Systems, Best,
The Netherlands). A quadrature wrap-around syner-
gy body coil was used as a receive coil. The following
scans from our MRI-protocol for surveillance after
EVAR were used for this study:
1. a transverse T1-weighted spin echo: TR/TE/
a¼ 580 ms/14 ms/90 , slice thickness 6.0 mm, FOV
270 385 mm2, acquisition matrix 179 256. 30
slices. Total acquisition time: 2.30 min.
2. a coronal 3D CE-MRA: TR/TE/a¼ 8.5 ms/2.1 ms/
45 , slice thickness 3.0 mm, FOV 360 450 mm2,
Matrix 154 512. 25 slices. Total acquisition time:
28 s with breath hold technique and 20 ml of con-
trast agent at 2.0 ml/s.
3. repeated post-contrast T1-weighted spin echo (as
pre-contrast).
A comparison of pre- and post-contrast T1-
weighted scans was used for endoleak detection and
classification. The high-resolution 3D CE-MRA scan
was used for additional information for endoleak clas-
sification. For the CE-MRA scan, 20 ml of Gd-DTPA
(Magnevist, Schering, Berlin, Germany) was adminis-
tered intravenously at a rate of at 2.0 ml/s, followed
by a saline chaser bolus (20 ml) injected at 1.5 ml/s.
Image analysis
Adequate evaluation of the post-operative analysis of
both CTA images and MRI images involves extensive
image post-processing.27 For endoleak detection
alone, only limited image post-processing is neces-
sary. All scans were loaded on to the graphical
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An Endoleak on CT was defined by a contrast
deposit or enhancement inside the aneurysm sac,
outside the graft. An Endoleak on MRI/MRA was
defined as increased signal intensity inside the aneu-
rysm sac outside the graft on the post-contrast T1-
weighted SE scan, which was not present on the
T1-weighted SE before contrast enhancement (Fig. 1).
Statistical analysis
For statistical analysis of the comparison between
CTA and MRI the Chi-square test was used. A p-value
of less than 0.05 was considered significant.
Results
Using MRI, an endoleak was detected in 23 of 35
(66%) evaluations. Using CT, in 11 of 35 scans an en-
doleak was detected (31%) ( p< 0.005, Chi-Square).
All endoleaks detected on CT were visible on MRI.
The main difference in endoleak detection between
CT and MRI was the higher sensitivity of MRI for
type II endoleaks (Table 1).
In 13 cases, delayed post-contrast CT series were
performed. These scans did not reveal an additional
endoleak. MRI evaluation revealed endoleaks in 4 of
these 13 cases (Fig. 2).
Based upon the MRI data 14 of the 23 detected en-
doleaks were classified as having an unknown origin
(61%). Using the CT data 5 of the 11 detected endo-
leaks were classified as having an unknown origin
(45%) ( p¼ 0.183, Chi-Square test).Discussion
This study shows that MRI techniques are more sensi-
tive in detecting endoleaks than CT. Furthermore, the
MRI protocol was more conclusive at identifying the
site of inflow of endoleaks. For several of the endo-
leaks detected by MRI, but not by CT, the origin
was hard to trace. Although the absolute number of
classified endoleaks by MRI was higher than by CTA,
the percentage of classified endoleaks was lower, due
to the high number of unclassified endoleaks detected
by MRI.
It must be noted that the current study only in-
cluded Ancure and Excluder endografts. All nitinol
stents are MR compatible.28 All fully supported en-
dografts show some amount of signal loss due to RF
caging. For most endografts MRI and MRA based
follow-up is an option. When considering the diag-
nostic interpretation of the imaging results, artifacts
caused by the metallic stents should be considered,
since these artifacts can mimic stenosis or occlusion
of the endograft.28
A more sensitive follow-up can help to identify
small and concealed endoleaks in patients with
a non-shrinking aneurysm sac or late aneurysm sac
enlargement. More exact information of the patent
vessels involved in a type II endoleak will facilitate
decision making and re-intervention (Fig. 2).
Table 1. A summary of the results of endoleak detection and
classification
No-
endoleak
Type
I
Type
II
Type
III
Type
IV
Endoleak of
unknown
origin
Total
MRI/MRA 12 (34%) 2 6 1 0 14 35
CTA 24 (69%) 2 3 1 0 5 35Fig. 1. A slice of a T1-weighted pre-contrast enhancement scan and the corresponding slice of the T1-weighted post-contrast
enhancement scan demonstrating an endoleak. L; denotes the graft lumen. E; denotes the endoleak.Eur J Vasc Endovasc Surg Vol 32, October 2006
364 M. J. van der Laan et al.Fig. 2. Axial cross sections at the same level in the same patient by CTA (A) and MRI (B) (post contrast T1-weighted spin
echo). The two arrows in A point at two vascular clips, which were placed on two lumbar arteries. The MRI image (B) shows
a type II endoleak coming from between the two vascular clips that CTA does not depict.For reasons of radiation dose reduction, only in pa-
tients who had aneurysm sac enlargement at previous
evaluations were delayed CTA series acquired at our
institution. This may theoretically have resulted in an
underestimation of the number of endoleaks in the
CTscans.28 However, the delayed series that performed
(13 cases), did not result in the detection of additional
endoleaks, whereas in 4 of these cases an endoleak was
found on MRI. In clinical practice only selected pa-
tients should be subjected to delayed CT imaging,
as the cumulated exposure of the patient to ionizing
radiation would be high.29 The use of dynamic MRA
techniques may obviate the need for such delayed
CT scans.30
It is customary to compare new diagnostic tests with
the current clinical gold standard. However, for MRI
scans, there are very unlikely to be false positive results.
In the comparison of the T1-weighted scans (scan 1 and
3), pre- and post-contrast enhancement, contrast en-
hancement in scan 3 (post CE scan), not seen on scan 1
(pre CE scan), can only result from contrast agent, for
that is the only difference between the two scans (Fig. 1).
Measurements of aneurysm sac pressure probably
will become available in the near future but the exact
added value of these measurements remains to be de-
termined.32 The presence of an endoleak gives only
limited information about short term treatment suc-
cess or outcome. In order to obtain complete insight
in aneurysm sac exclusion, the combined data of en-
doleak and its classification (type I, II, III or IV), aneu-
rysm sac size change over time and perhaps intra sac
pressure readings will be needed. Time resolved MRA
seems a good candidate to combine the advantages of
MRI over CT and time resolved over static imaging.
The implementation of SENSE (parallel imaging)
and ultra fast gradient systems into modern MRI
scanners have made fast dynamic scanning in 3DEur J Vasc Endovasc Surg Vol 32, October 2006(also: 4D scanning) possible. Time-resolved 3D MRA
datasets are constructed of sequential 3D volumes
containing information about the contrast dynamics.
Our recent experiences with this technique indicate,
as Lookstein et al. also has demonstrated, that time
resolved imaging might offer some additional ad-
vantages over static imaging techniques.31 We are cur-
rently investigating the additional clinical value of
such techniques.
This study demonstrates that the MRI protocol we
used was significantly more sensitive for endoleak de-
tection than CT. Perhaps the most important conclu-
sion that can be drawn from this study is that there
are many more endoleaks than previously assumed.
Many cases of endotension are likely to be caused
by a small endoleak not detected by CT. An MRI pro-
tocol for EVAR follow-up including time resolved
MRA is currently under investigation.
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